XLRN

Acceleron Pharma Inc

No insider bought or sold Acceleron Pharma Inc in the last 12 months

$0Bought, 12 mo

$0Sold, 12 mo

Follow XLRN

XLRN over the last year

Prices for XLRN aren't in yet.

XLRN after insider buys

3 months after each buy, from the first price a copier could get.

No buys have 3 months of prices yet. A record shows here at 3.

Every filing

96 insider filings since 2016, newest first

XLRNSell

Kevin F Mclaughlin · SVP, CFO and Treasurer

$1.2M−36.0%Jul 3

XLRNSell

Kevin F Mclaughlin · SVP, CFO and Treasurer

$154K−8.0%Apr 4

XLRNSell

Christopher Rovaldi · SVP, Program Mgmt, Ops

$134K−12.0%Apr 4

XLRNSell

Ravindra Kumar · SVP and Chief Scientific Officer

$46K−1.0%Apr 4

XLRNSell

John D Quisel · SVP, Corp. Dev., GC, Sec.

$46K−2.0%Apr 4

XLRNSell

Matthew L Sherman · EVP and Chief Medical Officer

$177K−6.0%Apr 4

XLRNSell

Richard F Pops · Director

$1.6M−55.0%Mar 8

XLRNSell

Christopher Rovaldi · SVP, Program Mgmt, Ops

$495K−31.0%Jan 17

XLRNSell

Kevin F Mclaughlin · SVP, CFO and Treasurer

$815K−31.0%Jan 4

XLRNSell

Christopher Rovaldi · SVP, Program Mgmt, Ops

$96K−8.0%Jan 4

XLRNSell

Ravindra Kumar · SVP and Chief Scientific Officer

$182K−4.0%Jan 4

XLRNSell

John D Quisel · SVP, Corp. Dev., GC, Sec.

$184K−8.0%Jan 4

XLRNSell

Matthew L Sherman · EVP and Chief Medical Officer

$198K−5.0%Jan 4

XLRNSell

Jean George · Director

$3.8M−99.0%Dec 18

XLRNBuy

Celgene Corp /de/ · 10% owner

$27.6M+14.0%Sep 25

XLRNSell

Kevin F Mclaughlin · SVP, CFO and Treasurer

$615K−25.0%Sep 14

XLRNSell

Christopher Rovaldi · SVP, Program Mgmt, Ops

$538K−34.0%Sep 14

XLRNSell

Ravindra Kumar · SVP and Chief Scientific Officer

$196K−5.0%Sep 14

XLRNSell

John D Quisel · SVP, Corp. Dev., GC, Sec.

$196K−8.0%Sep 14

XLRNSell

Matthew L Sherman · EVP and Chief Medical Officer

$707K−18.0%Sep 14

XLRNSell

Ravindra Kumar · SVP and Chief Scientific Officer

$463K−12.0%Aug 9

XLRNSell

Kevin F Mclaughlin · SVP, CFO and Treasurer

$1.1M−35.0%Jul 7

XLRNSell

Ravindra Kumar · SVP and Chief Scientific Officer

$30K−1.0%Jul 7

XLRNSell

Matthew L Sherman · EVP and Chief Medical Officer

$512K−13.0%Jul 7

XLRNSell

Kevin F Mclaughlin · SVP, CFO and Treasurer

$47K−2.0%Jan 6

XLRNSell

Ravindra Kumar · SVP and Chief Scientific Officer

$55K−2.0%Jan 6

XLRNSell

John D Quisel · SVP, Bus. Dev., GC, Secretary

$47K−3.0%Jan 6

XLRNSell

Matthew L Sherman · EVP and Chief Medical Officer

$55K−2.0%Jan 6

XLRNSell

Steven D Ertel · EVP and COO

$69K−2.0%Jan 6

XLRNBuy

Joseph S Zakrzewski · Director

$102KJan 3

XLRNSell

Terrance Mcguire · Director

$1.1M−4.0%Dec 9

XLRNSell

Jean George · Director

$17.4M−100.0%Nov 18

XLRNSell

John L Knopf · CEO and President

$3.2M−32.0%Nov 14

XLRNSell

Ravindra Kumar · SVP and Chief Scientific Officer

$1.8M−41.0%Oct 11

XLRNSell

Jean George · Director

$30.4M−65.0%Oct 4

XLRNSell

John D Quisel · SVP, Bus. Dev., GC, Secretary

$1.7M−45.0%Sep 23

XLRNSell

John D Quisel · SVP, Bus. Dev., GC, Secretary

$689K−22.0%Sep 13

XLRNSell

Kevin F Mclaughlin · SVP, CFO and Treasurer

$877K−31.0%Jul 6

XLRNSell

Matthew L Sherman · EVP and Chief Medical Officer

$903K−24.0%Jul 6

XLRNSell

Steven D Ertel · EVP and COO

$1.1M−20.0%Jul 6

XLRNSell

John L Knopf · CEO and President

$3.4M−46.0%Jul 6

XLRNSell

Kevin F Mclaughlin · SVP, CFO and Treasurer

$860K−27.0%May 25

XLRNSell

John L Knopf · CEO and President

$3.3M−45.0%May 20

XLRNSell

Steven D Ertel · EVP and COO

$1.0M−20.0%Apr 8

XLRNSell

Matthew L Sherman · EVP and Chief Medical Officer

$832K−22.0%Apr 8

XLRNBuy

Celgene Corp /de/ · 10% owner

$32.0M+17.0%Jan 11

Newer filings

Filings come from SEC EDGAR and prices from daily closes. Not investment advice.